Myconic Capital Corp. (MEDI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2021 | 07-2020 | 07-2019 | 07-2018 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 281 | 30 | N/A | N/A |
| Accounts receivable | -652 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 14 | -22 | 32 |
| Other Working Capital | -181 | -10 | -52 | 32 |
| Other Operating Activity | -1,726 | -623 | -564 | -274 |
| Operating Cash Flow | $-2,279 | $-590 | $-638 | $-210 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -2 | N/A | N/A | N/A |
| Net Acquisitions | -1,349 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -1,100 | -1,650 | N/A |
| Sale Of Investment | 125 | 1,056 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -115 | 0 |
| Investing Cash Flow | $-1,226 | $-44 | $-1,765 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -270 | -38 | N/A | N/A |
| Common Stock Issued | 4,540 | 0 | 3,500 | 2,244 |
| Common Stock Repurchased | N/A | 0 | -34 | N/A |
| Other Financing Activity | 13 | 0 | 8 | 7 |
| Financing Cash Flow | $4,282 | $-38 | $3,474 | $2,251 |
| Exchange Rate Effect | 26 | N/A | N/A | N/A |
| Beginning Cash Position | 2,517 | 3,189 | 2,118 | 77 |
| End Cash Position | 3,320 | 2,517 | 3,189 | 2,118 |
| Net Cash Flow | $777 | $-672 | $1,071 | $2,041 |
| Free Cash Flow | ||||
| Operating Cash Flow | -2,279 | -590 | -638 | -210 |
| Capital Expenditure | -2 | N/A | N/A | N/A |
| Free Cash Flow | -2,281 | -590 | -638 | -210 |